Literature DB >> 12456485

Determinants of Notch-3 receptor expression and signaling in vascular smooth muscle cells: implications in cell-cycle regulation.

Alexandre H Campos1, Wenli Wang, Matthew J Pollman, Gary H Gibbons.   

Abstract

The Notch family of receptors and ligands plays an important role in cell fate determination, vasculogenesis, and organogenesis. Mutations of the Notch-3 receptor result in an arteriopathy that predisposes to early-onset stroke. However, the functional role of the Notch signaling pathway in adult vascular smooth muscle cells (VSMCs) is poorly characterized. This study documents that the Notch-3 receptor, the ligand Jagged-1, and the downstream transcription factor, HESR-1, are expressed in the normal adult rat carotid artery, and that this expression is modulated after vascular injury. In cultured VSMCs, both angiotensin II and platelet-derived growth factor (PDGF) markedly downregulated Notch-3 and Jagged-1 through ERK-dependent signaling mechanisms and prevented the glycosylation of Jagged-1. The downregulation of Jagged-1 and Notch-3 was associated with a decrease in CBF-1-mediated gene transcription activation and a fall in the mRNA levels of the downstream target transcription factor HESR-1. To test the hypothesis that the Notch pathway was coupled to growth regulation, we generated VSMC lines overexpressing the constitutively active form of Notch-3 (A7r5-N3IC). These cells exhibited a biphasic growth behavior in which the growth rate was retarded during the subconfluent phase and failed to decelerate at postconfluence. The lack of cell-cycle arrest in postconfluent A7r5-N3IC was associated with an attenuated upregulation of the cell-cycle inhibitor p27(kip) relative to control cells. This study documents the regulation of the Jagged-1 and Notch-3 genes in VSMCs by growth factor stimulation as well as a role for Notch-3 as a determinant of VSMC growth.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12456485     DOI: 10.1161/01.res.0000044944.99984.25

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  55 in total

1.  The distribution of Notch receptors and their ligands during articular cartilage development.

Authors:  A J Hayes; G P Dowthwaite; S V Webster; C W Archer
Journal:  J Anat       Date:  2003-06       Impact factor: 2.610

Review 2.  Canonical and non-canonical Notch ligands.

Authors:  Brendan D'Souza; Laurence Meloty-Kapella; Gerry Weinmaster
Journal:  Curr Top Dev Biol       Date:  2010       Impact factor: 4.897

3.  Relationship between Notch receptors and hyperoxia-induced lung injury in newborn rats.

Authors:  Qianshen Zhang; Liwen Chang; Hanchu Liu; Zhihu Rong; Hongbing Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

4.  Notch: a mastermind of vascular morphogenesis.

Authors:  Leonard M Anderson; Gary H Gibbons
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

Review 5.  Notch Signaling in Vascular Smooth Muscle Cells.

Authors:  J T Baeten; B Lilly
Journal:  Adv Pharmacol       Date:  2016-08-26

Review 6.  The many facets of Notch ligands.

Authors:  B D'Souza; A Miyamoto; G Weinmaster
Journal:  Oncogene       Date:  2008-09-01       Impact factor: 9.867

7.  γ-Secretase inhibitor DAPT attenuates intimal hyperplasia of vein grafts by inhibition of Notch1 signaling.

Authors:  Yong Guang Xiao; Wei Wang; Dan Gong; Zhi Fu Mao
Journal:  Lab Invest       Date:  2014-04-21       Impact factor: 5.662

8.  Functional analysis of a recurrent missense mutation in Notch3 in CADASIL.

Authors:  T Haritunians; T Chow; R P J De Lange; J T Nichols; D Ghavimi; N Dorrani; D M St Clair; G Weinmaster; C Schanen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

9.  Thrombospondin 2 potentiates notch3/jagged1 signaling.

Authors:  He Meng; Xiaojie Zhang; Kurt D Hankenson; Michael M Wang
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

Review 10.  Impact of notch signaling on inflammatory responses in cardiovascular disorders.

Authors:  Thibaut Quillard; Beatrice Charreau
Journal:  Int J Mol Sci       Date:  2013-03-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.